- Global Pharma News & Resources

Challenges in Project Management within the Pharmaceutical Industry

Challenges in Project Management within the Pharmaceutical Industry


In the drug company trade, with more uncertainties from the method of a research project, project management becomes tougher.
  • Author Company: Veeprho Pharmaceuticals s.r.o
  • Author Name: Yuvraj Shinde
  • Author Email:
  • Author Website:
Editor: Yuvraj Shinde Last Updated: 14-Nov-2022

In the drug company trade, with more uncertainties from the method of a research project, project management becomes tougher. Project management within the pharmaceutical trade involves:

  1. Scope management
  2. Project coming up with, executing, and watching
  3. Timeline and budget coming up with and management
  4. Stakeholder management
  5. Management of regulative and compliance ways
  6. Environmental safety
  7. Risk management
  8. Team management

Challenges underlie each of those aspects of project management. The interdependencies between these components create even additional advanced. Whereas the developed product is also effective for the supposed use, it's going to need dangerous chemicals and ingredients within the production method. Any deviation from safety plans will produce long delays within the project timeline.

While changes square measure inevitable, it's natural that the stakeholders might internally or outwardly resist implementing an amendment. Making an associate in a Nursing atmosphere that embraces amendment is essential in managing the stakeholders. The project manager ought to regularly evolve his or her sort of approach to managing the stakeholders. Rising soft skills for effective communication are as vital as rising listening skills. A policy of “no surprises” and open communication is useful in preventing the delivery of incorrect info.

Recently, additional industries square measure moving toward matrix organization, in an exceeding matrix organization, there square measure four key players of project management: project manager, purposeful managers, higher management, and project team members.

While each of those parts has its role and responsibilities, interdependencies become inevitable. The project manager’s square measure challenged to keep this relationship viable to profit the project. Additionally, project managers within the pharmaceutical trade encounter challenges in the:

  1. Resource limitation
  2. Cross-functional team management
  3. Institution processes
  4. Cultural variations
  5. Customer management

With pressures to chop prices, resource limitation could be a major concern in project execution. A restricted pool of resources with desired technical experience makes it even harder to execute the work arrangement and meet the timeline. At the product-development stage, participating in cross-functional groups becomes a difficult task for the project manager. Typically the team members additionally work on multiple comes. The team members’ skills in prioritizing, realizing the importance of the tasks, and effective communication become crucial to the productivity of the matrix organization. Lack of communication between team members, and between team members and their purposeful managers, will produce a chaotic state of affairs at intervals during a project.

As businesses face continuous changes in client desires and regulative, quality, and safety needs, changes and updates in the business processes become an exhausting task to accomplish. Often, project managers fall into an exceedingly difficult state of affairs operating with non-current processes. Higher management's support in establishing clear business processes can facilitate the project manager and project team in accomplishing the project goal.

Managing cultural variations at intervals within the team, intervals within the host businesses, and on the client side could be a challenge that the project manager encounters frequently. Client management adds another layer of challenges in managing comes that involve inter-company collaboration and contract manufacturing organizations (CMOS). Ineffective management of the client's desires will yield scope creep, increasing the project budget and inflicting delays. Establishing the client's expectation in alignment with the scope early within the method helps in satisfying the purchasers. Project management acts because of the face of the host company to the client and contrariwise. This puts project management in an exceedingly tough state of affairs once the client's expectation doesn't match the guarantees the host company offered as per the agreement. operating with the client to develop a transparent scope definition within the early stages of the project is the desired approach to forestall any confusion.

Drug and API manufacturers face issues of impurities in the drugs, be it during manufacturing or storage. So to counter this problem Pharmaceutical Impurities Reference Standards are available in the Pharmaceutical market. These Impurity Reference Standards also act as the precursor for various components.

VEEPRHO is a global manufacturer and provider of Impurity Reference Standards for the Pharmaceutical trade. We tend to stand live involved in the analysis, development, and supply of synthesized impurities, metabolites, intermediates, and APIs with custom synthesis VEEPRHO Specialization includes:

  • Impurity isolation from API or drug merchandise by preceding HPLC.
  • Synthesis of Impurities/Metabolite.
  • Intermediates and Active Pharmaceutical ingredients

Our purpose is to produce vital merchandise required within the Pharmaceutical business in a very time-effective manner. High laws, product handiness, as well as the constant discovery of scientific impurities/metabolites, keep the United States busy, and we square measure committed to delivering as per your desires even providing custom synthesis.


  • International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). (2012). The Pharmaceutical Industry and Global Health: Facts and Figures 2012 Retrieved on 01 March 2014 from
  • Lichtenberg, Frank R. (2008). Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003. Retrieved on 01 March 2014 from
  • US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Division of Bacterial Diseases (DBD). (1998). Heliobacter pylori and Peptic Ulcer Disease. Retrieved on 01 March 2014 from